BioWorld MedTech

Jan. 22, 2014

Proteus continues momentum, receives $31.6M in venture funding

Proteus Digital Health (Redwood City, California) reported it has received $31.6 million in debt financing from Oxford Finance and Silicon Valley Bank. Read More

Covidien reports exiting its renal denervation program

Washington Roundup: FDA seeks standardized data format for filings with computational models

DePuy Synthes Spine launches new spinal fusion bone scaffold

Deals roundup: Teva Pharmaceutical in plan to acquire NuPathe for $144 million

BioWorld Survey: Let Us Know What You Think!

Financings roundup: ZipLine Medical closes C round for $4.3 million

HIT roundup: Nuance conducts study on physicians' attitudes toward clinical documentation

Patent watch: Titan Spine wins five new U.S. patents for Endoskeleton devices

Agreements/contracts: Edison launches search for therapeutic partners

Products

MDD's Oncology Extra

Today's news in brief

BioWorld

BioWorld briefs for Dec. 31, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 31, 2025.

Illustration of magnifying glass looking at cancer in the brain

Researchers discover how glioblastoma tumors dodge chemotherapy

BioWorld MedTech

Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...

Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact

BioWorld

Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...

Big pharma taps fast Asia innovation in search of next Keytruda

BioWorld

Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...